Oriola-KD Oyj (OKDBV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals and health and wellbeing products. It offers expert advice on health and wellbeing and quality products through pharmacies. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola's brands. It also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD is headquartered in Espoo, Finland.
Oriola-KD Oyj Key Recent Developments
Jul 18,2018: Oriola: Half year financial report 1 January-30 June 2018
May 29,2018: Oriola: Management Changes
Mar 14,2018: Changes in Oriola's Group Management team
Feb 13,2018: Oriolas Group Appoints Helena Kukkonen As Chief Financial Officer
Feb 13,2018: Oriola Financial Statements Release January-December 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Oriola-KD Oyj-Key Facts 6
Oriola-KD Oyj-Key Employees 7
Oriola-KD Oyj-Key Employee Biographies 8
Oriola-KD Oyj-Major Products and Services 9
Oriola-KD Oyj-History 10
Oriola-KD Oyj-Company Statement 11
Oriola-KD Oyj-Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2-Company Analysis 13
Company Overview 13
Oriola-KD Oyj-Business Description 14
Business Segment: Consumer 14
Key Stats 14
Business Segment: Healthcare 14
Key Stats 14
Business Segment: Services 14
Geographical Segment: Finland 15
Geographical Segment: Other Countries 15
Geographical Segment: Sweden 15
Oriola-KD Oyj-Corporate Strategy 16
Oriola-KD Oyj-SWOT Analysis 17
SWOT Analysis-Overview 17
Oriola-KD Oyj-Strengths 17
Oriola-KD Oyj-Weaknesses 18
Oriola-KD Oyj-Opportunities 19
Oriola-KD Oyj-Threats 20
Oriola-KD Oyj-Key Competitors 21
Section 3-Company Financial Ratios 22
Financial Ratios-Capital Market Ratios 22
Financial Ratios-Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios-Interim Ratios 27
Financial Ratios-Ratio Charts 28
Section 4-Company's Recent Developments 29
Jul 18, 2018: Oriola: Half year financial report 1 January-30 June 2018 29
May 29, 2018: Oriola: Management Changes 30
Mar 14, 2018: Changes in Oriola's Group Management team 31
Feb 13, 2018: Oriola Financial Statements Release January-December 2017 32
Feb 12, 2018: Oriola's new President and CEO joins the company 33
Jan 31, 2018: Recommendation by the Nomination Committee of Oriola concerning the Board of Directors to be elected by the 2018 Annual General Meeting 34
Dec 18, 2017: Robert Andersson appointed Oriola new President and CEO 36
Dec 18, 2017: Oriola's President and CEO to change 37
Dec 18, 2017: Oriola specifies the outlook for 2017 38
Oct 25, 2017: Oriola: Interim Report January-September 2017 39
Section 5-Appendix 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
List of Figures
Oriola-KD Oyj, Performance Chart (2013-2017) 26
Oriola-KD Oyj, Ratio Charts 28
List of Tables
Oriola-KD Oyj, Key Facts 6
Oriola-KD Oyj, Key Employees 7
Oriola-KD Oyj, Key Employee Biographies 8
Oriola-KD Oyj, Major Products and Services 9
Oriola-KD Oyj, History 10
Oriola-KD Oyj, Subsidiaries 12
Oriola-KD Oyj, Key Competitors 21
Oriola-KD Oyj, Ratios based on current share price 22
Oriola-KD Oyj, Annual Ratios 23
Oriola-KD Oyj, Annual Ratios (Cont...1) 24
Oriola-KD Oyj, Annual Ratios (Cont...2) 25
Oriola-KD Oyj, Interim Ratios 27
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44
Single User License:
Corporate User License:
Oral Hammaslaakarit Oyj
Biotie Therapies Corp
Oriola-KD Oyj, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"